Skip to main content

Table 1 Patients characteristics

From: Comparison of seventh and eighth edition of AJCC staging system in melanomas at locoregional stage

Variable

N (percentage)

Patient sex

Female

1382 (54.82%)

Male

1092 (43.32%)

Ulceration

Absent

1206 (47.84%)

Present

1017 (40.34%)

Unknown

251 (9.96%)

Microsatellites

Absent

2272 (90.12%)

Present

98 (3.89%)

Unknown

104 (4.13%)

In-transit

Absent

2366 (93.85%)

Present

85 (3.37%)

Unknown

23 (0.91%)

T feature

1a

135 (5.36%)

1b

318 (12.61%)

1, unable to stage otherwise

52 (2.06%)

2a

416 (16.5%)

2b

165 (6.55%)

2, unable to stage otherwise

43 (1.71%)

3a

278 (11.03%)

3b

359 (14.24%)

3, unable to stage otherwise

47 (1.86%)

4a

145 (5.75%)

4b

421 (16.7%)

4, unable to stage otherwise

39 (1.55%)

Unknown

56 (4.09%)

N feature

Negative

1560 (61.88%)

1a

252 (10%)

1b

103 (4.09%)

1c

45 (1.79%)

2a

116 (4.6%)

2b

93 (3.69%)

2c

32 (1.27%)

3a

38 (1.51%)

3b

129 (5.12%)

3c

70 (2.78%)

Unknown

36 (3.29%)

Sentinel lymph node biopsy status

Negative

1711 (67.87%)

Not conducted

292 (11.58%)

Positive

471 (18.68%)

Largest metastatic deposit in sentinel lymph node

Not applicable

1599 (64.63%)

Clinical (palpable)

292 (12.9%)

Unknown

212 (9.37%)

< 1 mm

112 (4.53%)

≥ 1 mm

259 (10.42%)

Year of diagnosis

Median

2004

Interquartile range

2002–2008

Age

Mean

51.69

Range

14–94

Breslow thickness (mm)

Median

2.5

Interquartile range

1.2–4.1